MAP2K7 and malignant colon neoplasm: The co-delivery of MEK inhibitor AZD6244 and cisplatin in hyaluronic acid-coated oleic acid nanoparticles to target CD44 was able to achieve significant toxicity in colon cancer when tested in vitro [10].